- Home
- PRTS vs KPTI Comparison
PRTS vs KPTI Comparison
Compare PRTS & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTS
- KPTI
- Stock Information
- Founded
- PRTS 1995
- KPTI 2008
- Country
- PRTS United States
- KPTI United States
- Employees
- PRTS N/A
- KPTI N/A
- Industry
- PRTS Auto & Home Supply Stores
- KPTI Biotechnology: Pharmaceutical Preparations
- Sector
- PRTS Consumer Discretionary
- KPTI Health Care
- Exchange
- PRTS Nasdaq
- KPTI Nasdaq
- Market Cap
- PRTS 47.8M
- KPTI 44.5M
- IPO Year
- PRTS 2007
- KPTI 2013
- Fundamental
- Price
- PRTS $0.88
- KPTI $4.20
- Analyst Decision
- PRTS Buy
- KPTI Buy
- Analyst Count
- PRTS 2
- KPTI 6
- Target Price
- PRTS $1.40
- KPTI $48.50
- AVG Volume (30 Days)
- PRTS 708.7K
- KPTI 86.5K
- Earning Date
- PRTS 05-13-2025
- KPTI 05-12-2025
- Dividend Yield
- PRTS N/A
- KPTI N/A
- EPS Growth
- PRTS N/A
- KPTI N/A
- EPS
- PRTS N/A
- KPTI N/A
- Revenue
- PRTS $569,935,000.00
- KPTI $142,126,000.00
- Revenue This Year
- PRTS $1.73
- KPTI $2.34
- Revenue Next Year
- PRTS $5.48
- KPTI $13.81
- P/E Ratio
- PRTS N/A
- KPTI N/A
- Revenue Growth
- PRTS N/A
- KPTI 1.19
- 52 Week Low
- PRTS $0.68
- KPTI $3.51
- 52 Week High
- PRTS $1.45
- KPTI $17.40
- Technical
- Relative Strength Index (RSI)
- PRTS 51.24
- KPTI 34.55
- Support Level
- PRTS $0.80
- KPTI $4.33
- Resistance Level
- PRTS $0.94
- KPTI $4.81
- Average True Range (ATR)
- PRTS 0.06
- KPTI 0.49
- MACD
- PRTS 0.01
- KPTI -0.13
- Stochastic Oscillator
- PRTS 67.32
- KPTI 2.41
About PRTS CarParts.com Inc.
CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. It serves as an end-to-end solution for automotive repair and maintenance resources, offering a seamless online shopping experience that empowers drivers along every part of their journey. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.
About KPTI Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company derives its revenue from United States.